- Home
- FEMY vs EPOW Comparison
FEMY vs EPOW Comparison
Compare FEMY & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- EPOW
- Stock Information
- Founded
- FEMY 2004
- EPOW 2014
- Country
- FEMY United States
- EPOW China
- Employees
- FEMY N/A
- EPOW N/A
- Industry
- FEMY Medical/Dental Instruments
- EPOW Business Services
- Sector
- FEMY Health Care
- EPOW Consumer Discretionary
- Exchange
- FEMY Nasdaq
- EPOW Nasdaq
- Market Cap
- FEMY 29.9M
- EPOW 24.8M
- IPO Year
- FEMY 2021
- EPOW 2021
- Fundamental
- Price
- FEMY $0.83
- EPOW $0.90
- Analyst Decision
- FEMY Strong Buy
- EPOW
- Analyst Count
- FEMY 3
- EPOW 0
- Target Price
- FEMY $8.67
- EPOW N/A
- AVG Volume (30 Days)
- FEMY 151.8K
- EPOW 16.4K
- Earning Date
- FEMY 08-07-2025
- EPOW 08-05-2025
- Dividend Yield
- FEMY N/A
- EPOW N/A
- EPS Growth
- FEMY N/A
- EPOW N/A
- EPS
- FEMY N/A
- EPOW N/A
- Revenue
- FEMY $1,699,232.00
- EPOW $64,997,741.00
- Revenue This Year
- FEMY $283.83
- EPOW N/A
- Revenue Next Year
- FEMY $161.03
- EPOW N/A
- P/E Ratio
- FEMY N/A
- EPOW N/A
- Revenue Growth
- FEMY 61.97
- EPOW 44.28
- 52 Week Low
- FEMY $0.69
- EPOW $0.55
- 52 Week High
- FEMY $1.80
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- FEMY 37.62
- EPOW 45.25
- Support Level
- FEMY $0.91
- EPOW $0.87
- Resistance Level
- FEMY $0.93
- EPOW $0.95
- Average True Range (ATR)
- FEMY 0.04
- EPOW 0.04
- MACD
- FEMY -0.01
- EPOW -0.01
- Stochastic Oscillator
- FEMY 5.12
- EPOW 14.59
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.